1. Computer Modelling and Synthesis of Deoxy and Monohydroxy Analogues of a Ribitylaminouracil Bacterial Metabolite that Potently Activates Human T Cells
- Author
-
Weijun Xu, Ligong Liu, Geraldine J. M. Ler, Paul V. Bernhardt, Jeffrey Y. W. Mak, and David P. Fairlie
- Subjects
Stereochemistry ,Riboflavin ,T cell ,Imine ,Receptors, Antigen, T-Cell ,Lymphocyte Activation ,010402 general chemistry ,01 natural sciences ,Mucosal-Associated Invariant T Cells ,Catalysis ,chemistry.chemical_compound ,Ribose ,medicine ,Humans ,Moiety ,Computer Simulation ,Uracil ,Schiff Bases ,Natural product ,Schiff base ,010405 organic chemistry ,Organic Chemistry ,T-cell receptor ,General Chemistry ,0104 chemical sciences ,medicine.anatomical_structure ,chemistry - Abstract
5-(2-Oxopropylideneamino)-6-d-ribitylaminouracil (5-OP-RU) is a natural product formed during bacterial synthesis of vitamin B2. It potently activates mucosal associated invariant T (MAIT) cells and has immunomodulatory, inflammatory, and anticancer properties. This highly polar and unstable compound forms a remarkably stable Schiff base with a lysine residue in major histocompatibility complex class I-related protein (MR1) expressed in antigen-presenting cells. Inspired by the importance of the ribityl moiety of 5-OP-RU for binding to both MR1 and the T cell receptor (TCR) on MAIT cells, each OH was removed in silico. DFT calculations and MD simulations revealed a very stable hydrogen bond between the C3'-OH and uracil N1H, which profoundly restricts flexibility and positioning of each ribityl-OH, potentially impacting their interactions with MR1 and TCR. By using deoxygenation strategies and kinetically controlled imine formation, four monodeoxyribityl and four monohydroxyalkyl analogues of 5-OP-RU were synthesised as new tools for probing T cell activation mechanisms.
- Published
- 2019